phone icon  Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

Continuous Glucose Monitoring Market

- Opportunities and Forecasts, 2012 - 2020
 Report Code: IC 0988
 Pages: 92
 Format: PDF Exel CD_rom
pub_n Published: Dec 2013
tab_nTables: 26
aut_nAuthor(s):

Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices that has increased adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps which are bridged by the innovative CGM. With continuous glucose monitoring, significant improvement has been observed in stabilizing elevated A1C levels which in turn reduces risk of developing long term diabetic complications. Other driving factors for CGM market are technological innovation in the form of artificial pancreas, increasing awareness among developed, developing and under developed economies, and rise in incidences of diabetic cases. However, factors such as strict regulatory impositions, inadequate reimbursement options for CGM, lack of accurate results and cost of the CGMs are restraining the market growth.The global continuous glucose monitors market generated revenue of $194.8 million in 2012 and is expected to reach market size of value $568.5 million by 2020, growing at a CAGR of 14.8% during 2013-2020. This growth is attributed to increase in technological innovations, namely launch of artificial pancreas, convenience offered by CGM over self monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM.

Global CGM market is segmented based on application as home settings, diagnostics and hospitals. Among all the application segments home settings is expected to generate maximum revenue by 2020.

North America is the maximum revenue-generating segment across the globe, mainly due to rapid acceptance of innovative technology, well-penetrated reimbursement system when compared with other geographies and rise in patient pool. Asia Pacific is expected to grow at a faster rate due to large patient pool, geographical expansion of market players, increase in income levels and improved living standards of the people.

Key market players in this market includes, Medtronics, Dexcom, Animas Corporation, Ypsomed AG, Omnipod and Miraculins, Inc inlcuding others. The major strategies adopted by the market players across geographies are Collaborations, Product launches and approvals. Collaborations in the regions focus on distribution and commercialization of the devices.

Continuous Glucose Monitoring Market brings good news for medical device manufacturers.

KEY BENEFITS

  • The report ranks the factors that are responsible to accelerate the market growth driven by upper hand of CGM over Self monitoring glucose devices, approval for artificial pancreas and many more
  • Market is forecast for the period 2013 - 2020 with market revenues for 2 historic years of 2010 and 2012
  • Identification and analysis of key pockets of investment for CGM manufacturers
  • Identification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the market
  • Analysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenario
  • The report identifies and profiles key market participants that would drive innovation in the CGM market

KEY MARKET SEGMENTS

GLOBAL MARKET, BY DEVICES

  • Transmitter and Receivers
  • Sensors
  • Insulin Pump

GLOBAL MARKET, BY APPLICATION

  • Diagnostics/Clinics
  • Hospitals
  • Home Settings

GLOBAL MARKET, BY AGE

  • Children and Teens
  • Youth
  • Middle, Elderly and Aged

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • Row

KEY AUDIENCES

  • Medical Devices Manufacturers
  • Research Institutions
  • Healthcare Institutions
Table Of Contents
* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name Chapter Price

Chapter: 1 INTRODUCTION

1.1 Objectives and Scope
1.2 Report Description
1.3 Key Benefits of the Report
1.4 Research Methodology

$0(SU) €0(SU) £0(SU)

Chapter: 2 EXECUTIVE SUMMARY

$195(SU) €0(SU) £0(SU)

Chapter: 3 GLOBAL CONTINUOUS GLUCOSE MONITORS MARKET OVERVIEW

3.1 Healthcare Expenditure on Diabetes Worldwide
3.2 Type-1 Diabetics to Remain Key Target for CGM Market

3.2.1 Type-1 Diabetes

3.2.1.1 Type-1 Diabetes in Young People

3.2.2 Type-2 Diabetes

3.2.2.1 Type-2 Diabetes in Young People

3.2.3 Gestational Diabetes
3.2.4 Other Types of Diabetes

3.3 Market Intelligence

3.3.1 Top Factors Impacting Continuous Glucose Monitors Market, 2013-2020

3.3.1.1 Fda Approval of Artificial Pancreas
3.3.1.2 Convenience Offered by CGM Over Self Monitoring Glucose Devices
3.3.1.3 Rise in Incidences of Diabetes Cases Globally
3.3.1.4 Earlier Detection of the Hypo and Hyperglycemic Events by CGM
3.3.1.5 Inadequate Reimbursement Options for CGM Serve as Barriers for its Adoption
3.3.1.6 Accuracy and Cost Acts as a Hindrance in Continuing Use of CGM
3.3.1.7 Strict Regulatory Impositions
3.3.1.8 Increase in Awareness Among Developing and Underdeveloped Economies

3.3.2 Top Three Winning Strategies in the Continuous Glucose Monitors Market
3.3.2.1 Global Market Players Positioning
3.3.3 Top Investment Pockets in Continuous Glucose Monitors Market

3.3.3.1 Continuous Glucose Monitors Market – by Device
3.3.3.2 Continuous Glucose Monitors Market – by Applications
3.3.3.3 Continuous Glucose Monitors Market – by Geography

3.4 Regulations
3.5 Reimbursement Scenario
3.6 Market Dynamics

3.6.1 Drivers

3.6.1.1 Convenience Offered by CGM Over Self Monitoring Glucose Devices
3.6.1.2 FDA Approval of Artificial Pancreas Enables Closing the Loop and Overcomes the Limitation of Current Diabetes Care Management System
3.6.1.3 Earlier Detection of the Hypo and Hyperglycemic Events by CGM
3.6.1.4 Rise in Incidences of Diabetes Cases Globally
3.6.1.5 Increase in Awareness Among the Population in Developing and Underdeveloped Economies

3.6.2 Restraints

3.6.2.1 Strict Regulatory Impositions
3.6.2.2 Inadequate Reimbursement Options for CGM Serve as Barriers for its Adoption
3.6.2.3 Accuracy and Cost Acts as a Hindrance in Continuing Use of CGM

3.6.3 Market Opportunity

3.6.3.1 Growth in Emerging Market

3.6.4 Winning Strategies for Mncs in Emerging Markets

3.6.4.1 Tailoring the Existing Products to the Local Market Needs
3.6.4.2 Adoption of a Proactive Hybrid Model Rather Than Distributor Management
3.6.4.3 Service Rendered Makes a Difference
3.6.4.4 Partnership and Acquisition Key to Enhance Reach and Market Position
3.6.4.5  Adopting An Emerging-Market Attitude

$595(SU) €0(SU) £0(SU)

Chapter: 4 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY DEVICES

4.1 Transmitter and Receivers
4.2 Sensors

4.2.1 Market Trend

4.2.1.1 Non-Invasive Glucose Sensors
4.2.1.2 Subcutaneous Sensors (Minimally Invasive Sensors)
4.2.1.3 Conventional Technology – Holter-Type Retrospective Sensors
4.2.1.4 Advanced Technology – Real-Time Sensors

4.3 Insulin Pump

4.3.1 Advantages of Insulin Pump
4.3.2 Disadvantages of Insulin Pump
4.3.3 Market Trend

$1395(SU) €0(SU) £0(SU)

Chapter: 5 CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET - BY APPLICATION

5.1 Diagnostics/Clinics
5.2 Hospitals
5.3 Home Settings
5.4 Role of CGM in Private Practice

5.4.1 Team Members
5.4.2 Clinical Space
5.4.3 Scheduling
5.4.4 Keeping the Patients Informed

$1195(SU) €0(SU) £0(SU)

Chapter: 6 CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET – BY AGE

6.1 Children and Teens
6.2 Youth
6.3 Middle Elderly and Aged

$495(SU) €0(SU) £0(SU)

Chapter: 7 CGM SYSTEMS MARKET BY GEOGRAPHY

7.1 North America
7.2 Europe
7.2.1 Financial Cost Incurred
7.3 Asia Pacific
7.4 Row

$695(SU) €0(SU) £0(SU)

Chapter: 8 COMPANY PROFILES

8.1 Medtronic Inc.

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Business Performance
8.1.4 Strategic Moves and Developments

8.1.4.1 Principal Strategies: Product Launch
8.1.4.2 Secondary Strategies: Approval
8.1.4.3 Other Strategies: Collaboration

8.1.5 SWOT Analysis & Strategic Conclusions

8.2 Dexcom Inc.

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Business Performance
8.2.4 Strategic Moves and Developments

8.2.4.1 Principal Strategies: Agreement/Partnership
8.2.4.2 Secondary Strategies: Acquisition

8.2.5 SWOT Analysis & Strategic Conclusions

8.3 Novo Nordisk

8.3.1 Company Profile
8.3.2 Company Snapshot
8.3.3 Strategic Moves and Developments
8.3.4 SWOT Analysis & Strategic Conclusions

8.4 Spring Health Solution Ltd

8.4.1 Company Profile
8.4.2 Company Snapshot
8.4.3 Strategic Moves and Developments

8.4.3.1 Principal Strategies

8.4.4 SWOT Analysis & Strategic Conclusions

8.5 Roche

8.5.1 Company Profile
8.5.2 Company Snapshot
8.5.3 Strategic Moves and Developments
8.5.4 SWOT Analysis & Strategic Conclusions

8.6 Animas Corporation

8.6.1 Company Profile
8.6.2 Company Snapshot
8.6.3 Strategic Moves and Developments

8.6.3.1 Principal Strategies

8.6.4 SWOT Analysis & Strategic Conclusions

8.7 Ypsomed AG

8.7.1 Company Profile
8.7.2 Company Snapshot
8.7.3 Strategic Moves and Developments

8.7.3.1 Principal Strategies: Product Expansion
8.7.3.2 Secondary Strategies: New Subsidiary
8.7.3.3 Other Strategies: Acquisition and Agreements

8.7.4 SWOT Analysis & Strategic Conclusions

8.8 Insulet Corporation

8.8.1 Company Profile
8.8.2 Company Snapshot
8.8.3 Strategic Moves and Developments

8.8.3.1 Principal Strategies

8.8.4 SWOT Analysis & Strategic Conclusions

 

LIST OF TABLES

TABLE 1 FEATURES OF CURRENTLY AVAILABLE STAND-ALONE CGM SYSTEMS (AS OF MARCH 2013)
TABLE 2 FEATURES OF CURRENTLY AVAILABLE INTEGRATED CGM SYSTEMS (AS OF MARCH 2013)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY PRODUCT CATEGORY, 2011-2020, ($MILLION)
TABLE 4 GLOBAL CGM TRANSMITTERS AND RECEIVERS MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 5 GLOBAL CGM SENSORS MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 6 GLOBAL CGM INSULIN PUMP MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 7 GLOBAL CGM MARKET BY APPLICATION SEGMENTS, 2011 - 2020, ($MILLION)
TABLE 8 GLOBAL CGM MARKET IN DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)
TABLE 9 GLOBAL CGM MARKET IN HOSPITALS, BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)
TABLE 10 GLOBAL CGM MARKET IN HOME SETTINGS, BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 11 GLOBAL CGM MARKET BY AGE, 2011 - 2020, ($MILLION)
TABLE 12 TYPE-1 DIABETES (0-14 YEARS), 2013
TABLE 13 FACTORS IMPACTING GEOGRAPHICAL REGIONS IN 2013 AND 2020
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 15 THE PREVALENCE OF DIABETES IN THE ADULT POPULATION ACROSS THE U.K. IN 2011
TABLE 16 PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS), 2013, EUROPE
TABLE 17 PREVALENCE ESTIMATES OF DIABETES, 2013 & 2035
TABLE 18 PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS), 2013, AFRICA REGION
TABLE 19 MEDTRONIC BUSINESS SNAPSHOT
TABLE 20 DEXCOM INC. BUSINESS SNAPSHOT
TABLE 21 NOVA NORDISK BUSINESS SNAPSHOT
TABLE 22 SPRING HEALTH SOLUTION LTD BUSINESS SNAPSHOT
TABLE 23 ROCHE BUSINESS SNAPSHOT
TABLE 24 ANIMAS CORPORATION BUSINESS SNAPSHOT
TABLE 25 YPSOMED AG BUSINESS SNAPSHOT
TABLE 26 INSULET CORPORATION BUSINESS SNAPSHOT


LIST OF FIGURES

FIG. 1 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, BY GEOGRAPHY ($BILLION)
FIG. 2 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, 20-79 YEARS ($BILLION)
FIG. 3 TREATMENT OF DIABETES, 2011
FIG. 4 SIMILARITIES IN CAUSE OF PRE-DIABETES AND TYPE-2 DIABETES
FIG. 5 CGM ADOPTION BY DIFFERENT TYPES OF DIABETES PATIENTS
FIG. 6 PREVALENCE OF TYPE-1 DIABETES, BY GEOGRAPHY, (THOUSAND)
FIG. 7 GLOBAL PREVALENCE OF TYPE-2 DIABETES IN 2000 & ESTIMATED PREVALENCE IN 2030
FIG. 8 TOP FACTORS IMPACTING CGM MARKET, 2013-2020
FIG. 9 TOP WINNING STRATEGY IN CGM MARKET, 2010 TO 2013 (SEPTEMBER)
FIG. 10 TOP WINNING STRATEGY IN CGM MARKET BY YEAR
FIG. 11 GLOBAL MARKET PLAYERS POSITIONING
FIG. 12 TOP INVESTMENT POCKETS IN CGM DEVICE MARKETS
FIG. 13 TOP INVESTMENT POCKETS IN CGM APPLICATION MARKETS
FIG. 14 TOP INVESTMENT POCKETS IN CGM GEOGRAPHY MARKETS
FIG. 15 NUMBER OF INCIDENCES OF DIABETES GLOBALLY, BY GEOGRAPHY (2000, 2011 & 2030)
FIG. 16 GDP PER CAPITA IN EMERGING ECONOMIES
FIG. 17 EMERGING MARKET CAPITALIZATION STRATEGIES
FIG. 18 GLOBAL CGM MARKET AMONG CHILDREN, 2011-2020, ($MILLION)
FIG. 19 GLOBAL CGM MARKET AMONG TEENS, 2011-2020, ($MILLION)
FIG. 20 GLOBAL CGM MARKET AMONG YOUTH, 2011-2020, ($MILLION)
FIG. 21 GLOBAL CGM MARKET AMONG MIDDLE ELDERLY, 2011-2020, ($MILLION)
FIG. 22 GLOBAL CGM MARKET AMONG AGED, 2011-2020, ($MILLION)
FIG. 23 NORTH AMERICA CGM MARKET, 2013-2020, ($MILLION)
FIG. 24 CASES OF DIABETES BY AGES IN NAC (1000S) (2013 E)
FIG. 25 EUROPE CGM MARKET, 2013-2020, ($MILLION)
FIG. 26 CASES OF DIABETES BY AGES IN EUROPE (1000S) (2013 E)
FIG. 27 ASIA PACIFIC CGM MARKET, 2013-2020, ($MILLION)
FIG. 28 TOP 10 COUNTRIES WITH DIABETES INCIDENCES 2013 AND 2035
FIG. 29 ROW CGM MARKET, 2013-2020, ($MILLION)
FIG. 30 FINANCIAL REVENUES BY BUSINESS UNITS (2013)
FIG. 31 FINANCIAL REVENUES BY GEOGRAPHY (2013)
FIG. 32 FINANCIAL REVENUES BY GEOGRAPHY (2012)

€0(SU) £0(SU)

The global continuous glucose monitors (CGM) market is at its emerging state. The market has witnessed launch of various continuous glucose monitoring devices in last 7 to 8 years with continuous improvement in technology. Furthermore, innovations are expected to translate the entire market scenario in the coming five to seven years. The open loop continuous glucose monitoring can now be regarded as closed with the introduction of artificial pancreas named MiniMed 530G with Enlite by Medtronic in September 2013. Launch of this product has taken diabetic care management to a next level. The market is overcoming several challenges towards the commercialization of closed loop CGMs due to significant focus on technological innovation. This is expected to take the concept of CGMs to a next level from research to large level adoption. Major factors driving the market growth are convenience offered by CGM over conventional glucose monitoring devices, earlier detection of the Hypo and Hyperglycemic events, global rise in incidences of diabetes cases, and awareness among global population.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User
$4515
Group User
$5325
Site User
$7350
Global User
$10680
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    The penetration of Mobiles is more than 100% in the developed markets and is rapidly gaining acceptance in the developing regions such as Asia-Pacific, Latin America and Africa. The rising exposure to smartphones with technologies such as 3G and 4G networks will further promote the adoption of mobile devices in most sectors, especially in healthcare systems. Technological advancements has eventually led to a transition from hospital-care to personal-care, as Mobile Healthcare systems offer seamless support and care to patients, as the technology overpowers geographical limitations.
    Nov 2013 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Mechanical ventilation is a lifesaving intervention for patients with respiratory disorders or even respiratory failure. It is a form of breathing assistance in which a patient is connected to a ventilator through an endotracheal tube directly applied to the airway.
    Apr 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Biopsy is the surgical removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissue. Biopsy procedures can be performed for almost any organ with the help of a specific biopsy device.
    May 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Heart block is the disease of cardiovascular electrical system, which controls the rhythm and rate of the heart. Heart block mainly occurs due to disturbed and slowed electrical signals across the heart. Heart block is categorized in two types on the basis of working of the cardiovascular electric signals; partial heart blocks and complete heart blocks. In the partial heart blocks, the cardiovascular electrical signals are partially blocked i.e., their influx to heart is delayed.
    Jun 2016 | View Details >>
  • ...
    Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices, which has increased the adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps that are bridged by the innovative CGM.
    Jun 2016 | View Details >>
  • ...
    A fluid Management and Visualization system is used to balance body fluid in order to prevent complications associated with an undesired fluid level. It is also used for the early diagnosis of critical medical conditions. Fluid management systems perform functions such as fluid irrigation, fluid warming, fluid filtration, fluid deficit monitoring etc. Growing inclination towards minimally invasive surgeries and technological advancements in fluid management and visualization system products are expected to supplement the market growth.
    Jun 2016 | View Details >>
  • ...
    The safety of patientsand operators is a primary concern when it comes to medical power supply.Advances in technology and innovation are significantly impacting the medical power supply market.The growing demand for medical equipment which is smaller, more efficient, more cost-effective, reliable, and lighter is also affecting market growth.
    Jun 2016 | View Details >>